We are live on ! Find out more
ASA

Armstrong Shaw Associates Portfolio holdings

AUM $95.2M
1-Year Est. Return 23.67%
This Fund
S&P 500
This Quarter Est. Return
+3.17%
1 Year Est. Return
+23.67%
3 Year Est. Return
+51.2%
5 Year Est. Return
+82.8%
10 Year Est. Return
+225.63%
AUM
$814M
AUM Growth
-$1.89B
Cap. Flow
-$1.89B
Cap. Flow %
-232.57%
Top 10 Hldgs %
36.7%
Holding
46
New
1
Increased
2
Reduced
35
Closed
3

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$17.9M
2
GE icon
GE Aerospace
GE
+$9M
3
VZ icon
Verizon
VZ
+$290K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$80M
2
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
+$79.1M
3
JPM icon
JPMorgan Chase
JPM
+$70.5M
4
F icon
Ford
F
+$70.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$69.9M

Sector Composition

Rank Sector Weight
1 Financials 23.88%
2 Healthcare 21.23%
3 Technology 14.45%
4 Consumer Discretionary 10.46%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
26
RTX Corp
RTX
$295B
$18.7M 2.3%
254,270
-582,504
-70% -$41.8M
AMGN icon
27
Amgen
AMGN
$212B
$18.6M 2.29%
150,874
-332,249
-69% -$40.3M
ORCL icon
28
Oracle
ORCL
$346B
$18.4M 2.26%
450,552
-1,044,091
-70% -$39.7M
ESRX
29
DELISTED
Express Scripts Holding Company
ESRX
$16.4M 2.02%
218,729
-661,197
-75% -$49.5M
GE icon
30
GE Aerospace
GE
$377B
$16.4M 2.01%
131,897
+72,868
+123% +$9M
ABBV icon
31
AbbVie
ABBV
$465B
$15.9M 1.96%
310,098
-716,288
-70% -$36.2M
ELV icon
32
Elevance Health
ELV
$83.7B
$15M 1.84%
150,445
-343,775
-70% -$31.1M
CVX icon
33
Chevron
CVX
$374B
$14.5M 1.78%
121,583
-297,046
-71% -$34.5M
PX
34
DELISTED
Praxair Inc
PX
$12.4M 1.52%
94,593
-223,735
-70% -$29M
ADT
35
DELISTED
ADT Corp
ADT
$11.1M 1.36%
370,539
-1,690,943
-82% -$55.8M
WBC
36
DELISTED
WABCO HOLDINGS INC.
WBC
$10.5M 1.29%
99,697
-300,929
-75% -$29.1M
BRK.A icon
37
Berkshire Hathaway Class A
BRK.A
$1.1T
$3.75M 0.46%
20
– –
VZ icon
38
Verizon
VZ
$201B
$2.27M 0.28%
47,670
+6,137
+15% +$290K
AAPL icon
39
Apple
AAPL
$4.99T
$405K 0.05%
21,140
-84
-0.4% -$1.6K
MYI icon
40
BlackRock MuniYield Quality Fund III
MYI
$715M
$272K 0.03%
20,000
– –
NXP icon
41
Nuveen Select Tax-Free Income Portfolio
NXP
$899M
$270K 0.03%
20,000
– –
NIO
42
DELISTED
NUVEEN MUNICIPAL OPPORTUNITY FUND INC
NIO
$261K 0.03%
19,000
– –
AMP icon
43
Ameriprise Financial
AMP
$48.3B
$222K 0.03%
2,020
– –
KMI icon
44
Kinder Morgan
KMI
$70.3B
– –
-1,498,374
Closed -$53.9M
LOW icon
45
Lowe's Companies
LOW
$122B
– –
-1,001,120
Closed -$49.6M
CAM
46
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
– –
-685,737
Closed -$40.8M
1
2

Similar funds

AEPLI
AH Equity Partners LSV II Menlo Park, California $95.6M AUM 8.86% 1-Year Est. Return
GG
Golden Green Seneca, South Carolina $97.4M AUM 20.83% 1-Year Est. Return
VI
Visa Inc San Francisco, California $89.1M AUM 1.85% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
WCM
Wavelength Capital Management Westport, Connecticut $85.9M AUM 1.63% 1-Year Est. Return
QT
Quantamental Technologies White Plains, New York $106M AUM 22.9% 1-Year Est. Return
OC
One01 Capital Burlingame, California $82.3M AUM 50.95% 1-Year Est. Return
KC
Kenfarb & Co Ashland, Kentucky $109M AUM 18% 1-Year Est. Return

Armstrong Shaw Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Armstrong Shaw Associates held 46 positions worth $814M, down 70% from $2.71B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Armstrong Shaw Associates withdrew a net $1.89B in Q1 2014, closing 3 positions and reducing 35 holdings. Its most notable exit was Kinder Morgan, an estimated $53.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Armstrong Shaw Associates opened a new position in DuPont de Nemours worth $18.7M.

  • Armstrong Shaw Associates's largest Q1 2014 buy was DuPont de Nemours: 152,240 shares worth $18.7M.
  • Armstrong Shaw Associates added most to GE Aerospace in Q1 2014, an estimated $9M increase.
  • Armstrong Shaw Associates's biggest Q1 2014 reduction was CVS Health, cutting an estimated $80M.
  • Armstrong Shaw Associates fully exited Kinder Morgan in Q1 2014, selling an estimated $53.9M.
  • Armstrong Shaw Associates's ten largest holdings make up 37% of its $814M portfolio in Q1 2014.
  • Armstrong Shaw Associates opened 1 new position and closed 3 in Q1 2014.
  • Armstrong Shaw Associates's portfolio value fell 70% quarter-over-quarter to $814M.

Based on Armstrong Shaw Associates's 13F filing for Q1 2014, filed 5 May 2014.